(Total Views: 326)
Posted On: 02/19/2019 10:00:15 AM
Post# of 72436
I may have this wrong, but I believe patents are required to be part of an new drug application (NDA) with FDA. This would seem to be significant in terms of negotiations with a partner at this point, especially if the phase III will be of short duration. Correct me if I am wrong about the NDA requirement.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)